ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

Finally, An FY01 Appropriation For NIH; NCI’s Share $3.757 Billion, A 13.5% Raise.

January 5, 2001

In Brief: Hatch Introduces Bill Banning Smoking On U.S. Public Conveyances; New OCC Staff Announced

January 16, 1987

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

NCI Will Encourage More Activity In Environment Carcinogenesis

June 21, 1974

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

March 30, 2001